Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart Failure
Status unconfirmed · Not applicable
Conditions studied: Heart Failure
In brief
The purpose of the study is to compare the effects of conivaptan and diuretics on renal blood flow and neurohormones.
Key facts
- Study ID
- NCT00924014
- Run by
- Hennepin County Medical Center, Minneapolis
- People needed
- 8
- Starts
- 2009-07-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2009-06-18
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Have a diagnosis of chronic congestive heart failure of any etiology
- Be between 18-80 years of age
- Able to provide consent
- Have a documented left ventricular ejection fraction within the last year of < 40%
- On a stable dose (no changes within 2 weeks) of 40 mg or greater daily dose of furosemide or its equivalent
- On standard HF therapy medications (ACEI or ARB and beta-blocker unless contraindicated)
- Have an estimated glomerular filtration rate (GFR) of 30 ml/minute or greater (based on the Cockcroft Gault calculation)
- Have a hemoglobin of > 10 grams/dl
- Have a negative urine pregnancy for women of childbearing years only
You may not qualify if…
- Acute coronary syndrome within 1 month
- Systolic blood pressure less than or equal to 90 mmHg at time of enrollment
- Poor peripheral venous access
- Severe concomitant disease which deemed by the investigator would render them unsuitable for this trial
- Allergy or contraindication to the use of iothalamate, PAH - Specifically any allergies to iodine or iodine containing products, history of asthma and hay fever which deemed by the investigator would render them unsuitable for this trial
Where it is running
- Hennepin county Medical Center — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.